News

Beam Therapeutics Inc.'s (NASDAQ:BEAM) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures
Key Insights Given the large stake in the stock by institutions, Beam Therapeutics' stock price might be vulnerable ...